SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SCIO Scios Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Linda Pearson who wrote (925)11/5/1998 8:04:00 AM
From: ubrx  Read Replies (1) | Respond to of 1477
 
Linda,
Thanks for the post. I wonder who the buyer and seller were on that trade? There must be more going on behind the scenes...


Jim



To: Linda Pearson who wrote (925)11/10/1998 9:14:00 AM
From: Tom Gebing  Read Replies (1) | Respond to of 1477
 
DJ 09:06 [SCIO] *STUDY SHOWS NESIRITIDE HAS ADVANTAGES OVER STANDARD DRUG
DJ 09:06 [SCIO] *SCIOS INC.'S NESIRITIDE FOR TREATING HEART FAILURE
DJ 09:05 [SCIO] *STUDY SHOWS SCIOS' NESIRITIDE CLINICALLY ADVANTAGEOUS
DJ 09:04 [SCIO] *SCIOS'S NESIRITIDE SHOWS BENEFIT TO HEART PATIENTS IN STUDY


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News